medigraphic.com
Instituto Nacional de Neurología y Neurocirugía

2021, Número 2

<< Anterior Siguiente >>

Arch Neurocien 2021; 26 (2)


Calidad de sueño, trastorno conductual del sueño MOR y somnolencia diurna en adultos con y sin Parkinson

Díaz-Pacheco A, Moo-Estrella J

Idioma: Ingles.
Referencias bibliográficas: 37
Paginas: 20-25
Archivo PDF: 265.83 Kb.


RESUMEN

En la enfermedad de Parkinson (EP), la mala calidad del sueño y los trastornos del sueño son una parte central de los síntomas no motores. El objetivo fue comparar la calidad del sueño (CS), el trastorno conductual del sueño MOR (TCS-MOR) y la somnolencia diurna excesiva (SDE) entre adultos con y sin enfermedad de Parkinson (EP). Un segundo objetivo fue conocer la relación de la CS y el TCS-MOR con la SDE en pacientes con EP. Método. Sesenta adultos (38% mujeres, edad promedio de 66.7 ± 8.11 años), 50% con diagnóstico de EP y 50% controles sanos. Instrumentos: Escala de Somnolencia de Epworth (ESE), Índice de Calidad de Sueño de Pittsburgh (ICSP) y Cuestionario del Trastorno Conductual del Sueño MOR, que fue diseñado para este estudio. Resultados. Se encontraron diferencias en la CS (EP = 9.90 ± 4.47 vs grupo control = 7.23 ± 4.71, t = 2.25, p = .028), y el porcentaje de casos con síntomas de TCS-MOR (EP = 30%, grupo control = 6.7%, ji2 = 5.455, p = 0.020). No se encontraron diferencias en SDE (EP = 7.43 ± 5.46 frente al grupo de control = 6.50 ±5.28, t = .673, p = .504). Con base en el análisis de regresión lineal, el aumento de SDE no se asoció con la CS, pero si se asoció con el TCS-MOR. En conclusión, el grupo con EP presenta una mala calidad de sueño y una mayor prevalencia de síntomas del TCS-MOR. La SDE no difiere entre adultos con y sin EP; sin embargo, el TCS-MOR se asoció con un aumento de SDE en el grupo con EP.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Cross-Alcalá LE, Vázquez-Castellanos JL. Prevalence of certain neurological diseases in the city of Tepatitlán, Jalisco, Mexico. Rev Mex Neuroci. 2002; 3: 71-6. http://previous.revmexneurociencia. com/wp-content/uploads/2014/07/Nm0022-01.pdf

  2. Gwinn K, David K, Swanson-Fischer C, Albin R, Hillaire-Clarke C, Sieber B, et al. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's disease biomarkers program. Biomarkers in Medicine. 2017;11(6):451-473. Doi: 10.2217/ bmm-2016-0370

  3. Koychev I, Okai D. Cognitive–behavioural therapy for nonmotor symptoms of Parkinson's disease: a clinical review. Evid Based Mental Health. 2017; 20(1):15-20. Doi: 10.1136/ eb-2016-102574

  4. Bellosta-Diago E, Lopez-del Val L, Santos-Lasaosa S, et al. Association between REM sleep behaviour disorder and impulse control disorder in patients with Parkinson's disease. Neurología (english edition). 2017; 32(8):494-99. Doi:10.1016/j. nrleng.2016.02.007

  5. Hsiao Y, Chen Y, Tseng C, Wu L, Perng D, Chen Y et al. Sleep disorders and an increased risk of Parkinson's disease in individuals with non-apnea sleep disorders: a population-based cohort study. J Sleep Res. 2017; 26(5):623-28. Doi: 10.1111/jsr.12545

  6. Chahine L, Amara A, Videnovic A. A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015. Sleep Med Rev. 2017; 35:33-50. Doi: 10.1016/j.smrv.2016.08.001

  7. Sateia. International classification of sleep disorders, 3rd edn. highlights and modifications. Chest. 2014; 146(5):1387-94. Doi: 10.1378/chest.14-0970

  8. Matar E, Lewis S. REM sleep behaviour disorder: not just a bad dream. Med J Australia. 2017; 207(6):262-8. Doi: 10.5694/ mja17.00321

  9. Zhang X, Sun X, Wang J, Tang L, Xie A. Prevalence of rapid eye movement sleep behavior disorder (RBD) in Parkinson’s disease: a meta and meta-regression analysis. Neurological Sciences. 2017; 38(1):163-170. Doi: 10.1007/s10072-016-2744-1

  10. Knie B, Mitra M, Logishetty K, Chaudhuri K. Excessive daytime sleepiness in patients with Parkinson's disease. CNS Drugs. 2011; 25(3):203-12. Doi: 10.2165/11539720-000000000-00000

  11. Shen Y, Huang J, Li J, Liu C. Excessive daytime sleepiness in Parkinson’s disease. Chin Med J. 2018; 131(8):974-81. Doi: 10.4103/0366-6999.229889

  12. Brodsky M, Godbold J, Roth T, Olanow C. Sleepiness in Parkinson's disease: A controlled study. Mov Disord. 2003; 18(6):668-72. Doi: 10.1002/mds.10429

  13. Xiang Y, Xu Q, Sun Q, Wang Z, Tian Y, Fang L, et al. Clinical Features and correlates of excessive daytime sleepiness in Parkinson's disease. Fron Neurol. 2019; 10. https://Doi. org/10.3389/fneur.2019.00121

  14. Tholfsen L, Larsen J, Schulz J, Tysnes O, Gjerstad M. Development of excessive daytime sleepiness in early Parkinson disease. Neurology. 2015; 85(2):162-8. Doi: 10.1212/ WNL.0000000000001737

  15. Sandoval-Rincon M, Alcalá-Lozano R, Herrera-Jimenez I, Jimenez-Genchi A. Validation epwort sleepiness scale in mexican population. Gac Med Mex. 2013;149(4):409-16. https://www. medigraphic.com/pdfs/gaceta/gm-2013/gm134d.pdf

  16. Hita-Contreras F, Martínez-López E, Latorre-Román P, Garrido F, Santos M, Martínez-Amat A. Reliability and validity of the spanish version of the Pittsburgh sleep quality index (psqi) in patients with fibromyalgia. Rheumatol Int. 2014; 34(7):929-36. Doi: 10.1007/s00296-014-2960-z

  17. Lebrun C, Gély-Nargeot MC, Bayard S. Insomnia comorbid to Parkinson's disease part I: epidemiology, assessment, and related factors. Geriatr Psychol Neuropsychiatr Vieil. 2020; 1, 18(3):321-30. English. Doi: 10.1684/pnv.2020.0874.

  18. Gjerstad M D, Wentzel-Larsen T, Aarsland D, Larsen J P. Insomnia in Parkinson’s disease: frequency and progression over time. J Neurol Neurosurg Psychiatry. 2007; 78(5): 476-479. Doi: 10.1136/jnnp.2006.100370

  19. Stefani A, Högl B. Sleep in Parkinson’s disease. Neuropsychopharma. 2020; 45:121–8. https://Doi.org/10.1038/s41386-019-0448-y

  20. González-Naranjo JE, Alfonso-Alfonso M, Grass-Fernandez D, Morales-Chacón LM, et al. Analysis of sleep macrostructure in patients diagnosed with Parkinson's disease. Behav Sci (Basel). 2019; 8, 9(1):6. Doi: 10.3390/bs9010006.

  21. Jasti DB, Mallipeddi S, Apparao A, et al. Quality of sleep and sleep disorders in patients with parkinsonism: A polysomnography based study from rural South India. J Neurosci Rural Pract. 2018; 9(1): 92-9. Doi: 10.4103/jnrp.jnrp_189_17.

  22. Shafazand S, Wallace DM, Arheart KL, Vargas S, et al. Insomnia, Sleep quality, and quality of life in mild to moderate Parkinson's disease. Ann Am Thorac Soc. 2017; 14(3): 412-9. Doi: 10.1513/ AnnalsATS.201608-625OC.

  23. Zhu K, van Hilten JJ, Marinus J. The course of insomnia in Parkinson's disease. Parkinsonism and related disorders. 2016; 33, 51-57. Doi: 10.1016/j.parkreldis.2016.09.010

  24. Tholfsen LK, Larsen JP, Schulz J, Tysnes OB, Gjerstad MD. Changes in insomnia subtypes in early Parkinson disease. Neurol. 2017; 88(4), 352-8. Doi: 10.1212/WNL.0000000000003540

  25. Lysen TS, Darweesh SKL, Ikram MK, Luik AI, Ikram MA. Sleep and risk of parkinsonism and Parkinson's disease: a population-based study. Brain. 2019; 142(7):2013-22. Doi: 10.1093/brain/awz113.

  26. Moo Estrella J. Sueño y Pakinson. En Entendiendo al paciente con enfermedad de Parkinson. Salazar Ceballos, et al. 2018; (8):103-119. https://www.researchgate.net/ publication/350372741_Sueno_y_Parkinson

  27. Nodel M, Ukraintseva Y, Yakhno N. Syndrome of rapid eye movement sleep behavior disorder and Parkinson's disease in nocturia. Nevrologii zhurnal imeni SS Korsakova i psikhiatrii. 2017;117(9):15-20. Doi: 10.17116/jnevro20171179115-20

  28. Kim J, Criaud M, Cho S, Díez-Cirarda M, Mihaescu A, Coakeley S, et al. Abnormal intrinsic brain functional network dynamics in Parkinson’s disease. Brain. 2017; 140(11):2955-67. Doi: 10.1093/brain/awx233

  29. Xie D, Shen Q, Zhou J, Xu Y. Non-motor symptoms are associated with REM sleep behavior disorder in Parkinson's disease: a systematic review and meta-analysis. Neurol Sci. 2020; 42(1):47- 60. Doi: 10.1007/s10072-020-04769-9.

  30. Rolinski M, Szewczyk-Krolikowski K, Tomlinson PR, Nithi K, Talbot K, Ben-Shlomo Y, et al. REM sleep behaviour disorder is associated with worse quality of life and other non-motor features in early Parkinson's disease. J Neurol Neurosurg Psychiatry. 2014; 85:560–6. Doi: 10.1136/jnnp-2013-306104.

  31. Arnulf I, Neutel D, Herlin B, Golmard JL, et al. Sleepiness in Idiopathic REM sleep behavior disorder and Parkinson disease. Sleep. 2015; 38(10):1529–35. https://Doi.org/10.5665/ sleep.5040

  32. Liguori C, Mercuri NB, Albanese M, Olivola E, Stefani A, Pierantozzi M. Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease. J Neurol. 2019; 266(3):636-41. Doi:10.1007/s00415-018-09179-8.

  33. Patel N, LeWitt P, Neikrug AB, Kesslak P, Coate B, Ancoli-Israel S. Nighttime sleep and daytime Sleepiness improved with pimavanserin during treatment of Parkinson's disease psychosis. Clin Neuropharmacol. 2018; 41(6):210-215. Doi: 10.1097/ WNF.0000000000000307.

  34. Naismith SL, Rogers NL, Mackenzie J, Hickie IB, Lewis SJ. The relationship between actigraphically defined sleep disturbance and REM sleep behaviour disorder in Parkinson's Disease. Clin Neurol Neurosurg. 2010; 112(5):420-3. Doi:10.1016/j. clineuro.2010.02.011.

  35. Dickson DW. Neuropathology of Parkinson disease. Parkinsonism Relat Disord. 2018; 46(S1):S30-S33. Doi:10.1016/j. parkreldis.2017.07.033.

  36. Avorn J, Schneeweiss S, Sudarsky LR, Benner J, Kiyota Y, Levin R, et al. Sudden uncontrollable somnolence and medication use in Parkinson disease. Arch Neurol. 2005; 62:1242–8. Doi: 10.1001/ archneur.62.8.1242.

  37. Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U, et al. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease. Mov Disord. 2003; 18:659-67. Doi: 10.1002/mds.10417




2020     |     www.medigraphic.com